Deliberate release into the E.U.
environment of GMOs for any other purposes than placing on the
market:
Testing of NK603 maize varieties
tolerant to glyphosate herbicide - Pioneer Hi-Bred Spain S.L. -
Spain |
Date of publication: March 3,
2005
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification
report
General information
Notification Number: B/ES/05/08
Member State:Spain
Date of Acknowledgement:11/02/2005
Title of the Project:
Testing of NK603 maize varieties tolerant to glyphosate
herbicide.
Proposed period of release From:01/04/2005
To:31/12/2008
Name of the Institute(s) or Company(ies): PIONEER
HI-BRED SPAIN S.L.;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
NK603 maize varieties have been genetically modified to
tolerate application of glyphosate herbicide, which allows the
farmers to use a broad-spectrum, non-selective, systemic
herbicide for the weeding of the maize fields.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
NK603 maize, from Monsanto, has been genetically modified by
the introduction of cp4epsps genes, from Agrobacterium sp.
strain CP4, that confer tolerance to glyphosate herbicide,
together with only their regulatory components necessary for
expression.
6. Brief description of the method used for the genetic
modification:
The genetic modification was done using particle acceleration
method by Monsanto. Subsequently, maize plants tested in the
trials have been obtained by traditional breeding.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
Several types of trials are planned, to collect various maize
tissue samples for protein expression analysis and to collect
data on the agronomic value and insect resistance of NK603 maize
varieties.
2. Geographical location of the site:
The release is planned at the following locations in Spain in
2005:
- Aragón: Pastriz (Zaragoza), Gurrea de Gállego (Huesca).
- Cataluña: Alpicat (Lérida), Alguaire (Lérida).
- Madrid: Estremera (Madrid).
- Navarra : Fustiñana (Navarra)
- Castilla-La Mancha : Membrilla (Ciudad Real)
- Castilla-León: Calvarrasa de Abajo (Salamanca)
3. Size of the site (m2):
In 2005, each site could have up to 1000 m² sown with the
genetically modified maize subject of this notification (NK603
maize), the total trial surface (all varieties and borders
included) being larger.
In the following years, there could have up to 5000 m² of the
genetically modified maize subject of this notification (NK603
maize) sown per site, the total trial surface at each site (all
varieties and borders included) being larger.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Field trials with this genetically modified maize were
conducted at several locations and no environmental problems
were reported for these trials. The transgenic plants behaved as
conventional maize. They were indistinguishable from the
non-genetically modified maize plants except for showing
herbicide tolerance when glyphosate was applied, trait due to
the genetic modification.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or to the environment
from the deliberate release of genetically modified maize
tolerant to glyphosate are expected, as per information
contained in Summary Notification Information Format of
notification C/ES/03/01.
Brief description of any measures taken for the management of
risks:
In order to limit any pollen flow from the genetically
modified plants, a 200m-isolation distance will be maintained to
any other non-experimental maize crop. In addition, the trial
site will be surrounded by four border rows of conventional
maize of a similar relative maturity that will be also destroyed
at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When seeds need to be collected
for analysis; this will be done by sampling the whole ear and
unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide other than glyphosate
or by mechanical destruction, and incorporation into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil.
Volunteer maize will be monitored during the following year. An
herbicide treatment (other than glyphosate) will be used in
order to ensure destruction if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release. |
|
|